Tag: Mr Johnson
Prime Minister Boris Johnson has granted China’s Huawei a limited role in Britain’s 5G mobile network, resisting US pressure to exclude the company from next generation communications on fears China could use it to steal secrets.
- Huawei will be excluded from sensitive “core” parts and banned from nuclear sites
- US says it fears the Chinese network giant could steal secrets
- Huawei says UK’s “evidence-based decision” will ensure a competitive market
In the biggest test of his post-Brexit foreign policy to date, Mr Johnson on Tuesday ruled that “high-risk vendors” would be allowed into the “non-sensitive” parts of 5G networks, but their involvement would be capped at 35 per cent.
They would be excluded from the sensitive core of networks, where data is processed, and banned from all critical networks and sensitive locations such as nuclear sites and military bases, the government said.
Why is Huawei so controversial?
The dramatic arrest in Canada of Huawei’s chief financial officer for possible extradition to the US shocked many. But what exactly is Huawei and why does it seem like it’s continually being targeted by foreign governments?
The decision will dismay President Donald Trump’s administration, which fears China could use Huawei to steal secrets and has warned that if London gives Huawei a role then it could scale back intelligence cooperation.
“This is a UK-specific solution for UK-specific reasons and the decision deals with the challenges we face right now,” Communications Secretary Nicky Morgan said following a meeting of the National Security Council chaired by Mr Johnson.
Huawei was not mentioned by name in the British government’s statement, but British cyber security officials said they had always treated the company as a “high risk” vendor.
The White House and US state department did not immediately respond to a request for comment.
Huawei applauds ‘evidence-based decision’
Huawei, though, was happy.
“Huawei is reassured by the UK government’s confirmation that we can continue working with our customers to keep the 5G roll-out on track,” said Huawei Vice President Victor Zhang.
“This evidence-based decision will result in a more advanced, more secure and more cost-effective telecoms infrastructure that is fit for the future.
“It gives the UK access to world-leading technology and ensures a competitive market.”
Sources told Reuters last week senior British officials had proposed granting Huawei a limited role in the 5G network — a “calculated compromise” that could be presented to Washington as a tough restriction but also accepted by British operators already using the company’s equipment.
Huawei, the world’s biggest producer of telecoms equipment, says the United States wants it blocked from Britain’s 5G network because no US company can offer the same range of technology at a competitive price.
The US has argued that as 5G technology evolves, the distinction between the “edge” and “core” will blur as data is processed throughout the network, making it difficult to contain any security risks.
Huawei’s equipment is already used by Britain’s biggest telecoms companies such as BT and Vodafone, but it has been largely deployed at the “edge” of the network and excluded in the “core” where data is processed.
Huawei blacklisted by US
The world’s biggest maker of telecom network equipment and the second-largest smartphone maker was all but banned by Washington in 2019 from doing business with US companies.
The US Government alleges Huawei equipment poses national security risks because it could be used by the Chinese Government to spy on users. Huawei has repeatedly denied its products are a security threat.
The US has urged other countries not to buy the company’s 5G mobile network equipment.
Australia is the only country to have categorically ruled out Huawei’s participation in the construction of its 5G network.
In the US, Huawei is only banned from participating in government contracts, while New Zealand’s spy agency banned mobile company Spark from using Huawei equipment in its planned 5G upgrade.
In December 2019, the Chinese telecoms giant said “survival” will be its priority in 2020 after announcing lower than expected annual sales revenue, largely as the result of a US trade blacklisting.
A beloved family dog who was given three months to live after being diagnosed with a rare type of cancer is still living years later, after taking part in a Queensland clinical trial.
- Rottweiler Griffin’s tumours were growing at a rapid rate
- Undergoes treatment that uses part of a tumour to create bespoke vaccine
- UQ researchers looking for more dogs to prove the vaccine works to send cancer into remission
Adam Johnson noticed a lump on his dog Griffin’s back in December 2017.
“I thought we’d take him for a routine check,” Mr Johnson said.
“It didn’t seem like anything untoward, I just thought it would be medication and ‘he’ll be right’ sort of thing.
“A few days later we found out it was a cancerous lump.
“It was devastating, absolutely devastating right before Christmas.”
The rottweiler was diagnosed with T-cell lymphoma and given three months to live.
Veterinarian and University of Queensland PhD candidate Dr Annika Oksa said that type of cancer was usually a death sentence for dogs.
“He had a really big lump taken off his side but by the time he went back to have his stitches removed from the original surgery, he had another three lumps, so they were growing really quickly,” Dr Oksa said.
Rather than the more traditional route of chemotherapy, Griffin was enrolled in a medical trial using immunotherapy treatment, designed to “wake up” the dog’s own immune system so it recognised a foreign cancer.
“I took a sample from his tumour, at the time when I saw him he had 11 lumps on him,” Dr Oksa said.
Once a dog was diagnosed with the cancer, the trial’s researchers removed a small piece of the tumour and mixed it with a chemical to bolster the dog’s immune response.
This was then injected back into the dog as a vaccine, each week for a number of weeks or months.
“With this one we make it specifically from the dog’s own tumour,” Dr Oksa said.
“So it’s very, very personalised and then we hope that the dog’s own immune system will recognise the cancer and start fighting it.”
Mr Johnson said as the weeks of treatment progressed, he was surprised by the results.
“One by one, the cancerous legions began to disappear to the point where two years on we’ve still got him here,” Mr Johnson said.
“At that point in time it felt like a Hail Mary.
“My little girl has still got her dog.”
Dr Oksa said researchers were encouraged by the results.
“Eventually at about week eight or so, when it came time to have a look at him again there were no lumps. That was fantastic,” she said.
“Griffin is really rare because he had such a bad disease.
“We’ve had a number of dogs respond to this treatment and do really well but they were ones we’d hope would respond. With Griffin it was a surprise.
“We’re hoping that this will be a way forward to include in the treatment protocol for these dogs.
“We need to have more dogs in the trials obviously, so we have more evidence.
“So at the same time we’re researching what happens to the tumours, how do they respond to the vaccine — can we make any changes to it? Or combine it with different treatments.”
Scientists hope to expand the research into human trials for similar cancers in years to come.